Clinical trial NCT01712009 - References

Bone Pain in Stage I - III Breast Cancer — NOLAN: Naproxen or Loratadine and Neulasta

Citation(s)

•   Kirshner JJ, McDonald MC 3rd, Kruter F, Guinigundo AS, Vanni L, Maxwell CL, Reiner M, Upchurch TE, Garcia J, Morrow PK
  NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim. Support Care Cancer. 2017 Nov 16. doi: 10.1007/s00520-017-3959-2. [Epub ahead of print]

Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim

Details for clinical trial NCT01712009